Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Anaemia+1

Not recruiting

InvestigationalNo placebo

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ag-946

Contact Research Centre

Urea cycle disorder+3

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hhalpc

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Clobetasol

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drugNo placebo

Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Not recruiting

Investigational

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Investigational

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you – page 53

674 trials match your criteria

Hepatocellular carcinoma

Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Renal cell carcinoma

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Hepatitis D

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Pulmonary hypertension

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Anaemia+1

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

Urea cycle disorder+3

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

Dermatitis atopic

Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

Non-small cell lung cancer+2

Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Prostate cancer

Study on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Acute myeloid leukaemia

Study on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.